Skip to the page

Data / Drug companies / Amoxicillin and clavulanate potassium

Amoxicillin and clavulanate potassium: 35 companies and 203 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Amoxicillin and clavulanate potassium is listed in the FDA National Drug Code Directory by 35 companies, with 203 products in commercial distribution. 189 of the products (93.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for suspension; tablet, and the newest product started marketing on September 21, 2026.

The request: Get every company that lists amoxicillin and clavulanate potassium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
35
Products
203
Generic (ANDA) products
189 (93.1%)
Application numbers
33
Routes
Oral
Brand names
Augmentin, Augmentin Es-600
openFDA record search
api.fda.gov

Companies that list amoxicillin and clavulanate potassium

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
NuCare Pharmaceuticals,Inc.31tablet, film coated; powder, for suspensionGeneric drugs (ANDA)September 19, 2022
A-S Medication Solutions17powder, for suspension; tablet, film coatedGeneric drugs (ANDA)November 21, 2022
Preferred Pharmaceuticals Inc.13tablet, film coated; powder, for suspensionGeneric drugs (ANDA)July 31, 2026
Remedyrepack Inc.10tablet, film coated; tabletGeneric drugs (ANDA)September 21, 2026
Asclemed USA, Inc.9tablet, film coated; powder, for suspensionGeneric drugs (ANDA)May 1, 2020
Proficient Rx LP9tablet, film coated; powder, for suspensionGeneric drugs (ANDA)January 20, 2012
PD-Rx Pharmaceuticals, Inc.8tablet, film coated; tabletGeneric drugs (ANDA)August 23, 2016
Sportpharm LLC8tablet, film coated; tablet, multilayer, extended releaseGeneric drugs (ANDA)August 12, 2019
Bryant Ranch Prepack7tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Chartwell RX, LLC7powder, for suspension; tabletGeneric drugs (ANDA)March 22, 2005
Proficient Rx LP7tablet, film coated; powder, for suspensionGeneric drugs (ANDA)May 1, 2020
Sandoz Inc7tablet, film coated; powder, for suspensionGeneric drugs (ANDA)April 21, 2010
Aurobindo Pharma Limited6tablet, film coated; powder, for suspensionGeneric drugs (ANDA)January 20, 2012
NorthStar Rx LLC6tablet, film coated; powder, for suspensionGeneric drugs (ANDA)January 20, 2012
USAntibiotics, LLC6for suspension; tablet, coatedAuthorized generics (NDA)December 15, 2025
Bryant Ranch Prepack5tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Devatis, Inc.5powder, for suspension; tablet, film coatedGeneric drugs (ANDA)November 1, 2024
Teva Pharmaceuticals USA, Inc.5powder, for suspension; tablet, film coatedGeneric drugs (ANDA)January 13, 2005
Hikma Pharmaceuticals USA Inc.4powder, for suspension; tabletGeneric drugs (ANDA)August 23, 2016
Proficient Rx LP4powder, for suspension; tablet, film coatedGeneric drugs (ANDA)November 21, 2022
American Health Packaging3tablet, film coatedGeneric drugs (ANDA)July 26, 2024
Micro Labs Limited3tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Advanced Rx of Tennessee, LLC2tablet, film coatedGeneric drugs (ANDA)March 3, 2023
Aurobindo Pharma Limited2powder, for suspensionGeneric drugs (ANDA)April 19, 2019
Bryant Ranch Prepack2tablet, film coatedGeneric drugs (ANDA)January 20, 2012
Coupler LLC2tablet, film coatedGeneric drugs (ANDA)May 7, 2026
Hawaii Repack, Inc.2powder, for suspensionGeneric drugs (ANDA)December 20, 2011
Medsource Pharmaceuticals2tablet, film coatedGeneric drugs (ANDA)March 1, 2017
Northwind Health Company, LLC2tablet, film coatedGeneric drugs (ANDA)October 17, 2024
PD-Rx Pharmaceuticals, Inc.2tablet, film coatedGeneric drugs (ANDA)October 31, 2002
PD-Rx Pharmaceuticals, Inc.2tablet, film coatedGeneric drugs (ANDA)October 31, 2002
Redpharm Drug2for suspension; powder, for suspensionAuthorized generics (NDA)September 19, 2022
Allegis Holdings, LLC1for suspensionNew drug applications (NDA)September 1, 2023
Cipla USA Inc.1suspensionGeneric drugs (ANDA)October 28, 2024
Direct_Rx1tablet, film coatedGeneric drugs (ANDA)October 7, 2021

Dosage forms

Dosage formProductsShare
Tablet, film coated11255.2%
Powder, for suspension5426.6%
Tablet136.4%
For suspension73.4%
Suspension73.4%
Tablet, coated52.5%
Tablet, multilayer, extended release21%
Tablet, chewable21%
Tablet, film coated, extended release10.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)18993.1%
Authorized generics (NDA)115.4%
New drug applications (NDA)31.5%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.